-
-
-
-
-
-
-
Clearmind Medicine Announces Additional Topline Positive Safety Results Reinforcing Favorable Profile of CMND-100 in Ongoing Phase I/IIa Clinical Trial
-
-
-
-
-
-
-
Clearmind Medicine Inc. Files Annual Report on Form 20-F for the Fiscal Year Ended October 31, 2025
-
-
-
-
-
-
-
Clearmind Medicine completes second cohort enrollment in AUD trial
-
-
-
-
-
-
-
Clearmind Medicine Successfully Regains Compliance with Nasdaq's Minimum Stockholders' Equity Requirement
-
-
-
-
-
-
-
Clearmind Medicine receives safety board approval for alcohol disorder trial
-
-
-
-
-
-
-
Clearmind Medicine Accelerate FDA-Approved Alcohol Use Disorder Clinical Trial by Activating Fifth Elite Global Medical Site
-
-
-
-
-
-
-
Clearmind Medicine Receives Final Approval to Expand its FDA Regulated Phase 1/2a Clinical Trial for Alcohol Use Disorder at Hadassah Medical Center
-
1,122,779 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

